KPTI Karyopharm Therapeutics Inc.
Healthcare$8.98+0.00%OpenMarket Cap: $76.7M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$17.25
Target (Median)
$14.50
Target Range
$12.00 - $28.00
Upside from current price: 92.1%
Rating Distribution
2 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-27 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-25 | Baird | maintain | Outperform | Outperform |
| 2026-02-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-04 | RBC Capital | maintain | Outperform | Outperform |
| 2025-10-13 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2025-10-09 | Baird | maintain | Outperform | Outperform |
| 2025-10-09 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-08-12 | Baird | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.12 | $155.3M | 3 |
| Sun Dec 31 | $-1.54 | $230.0M | 3 |
| Mon Dec 31 | $1.49 | $417.5M | 1 |
| Tue Dec 31 | $3.68 | $611.4M | 1 |